Novartis Unit To Appeal German Laxative Ban

Law360, New York (February 7, 2008, 12:00 AM EST) -- Novartis AG subsidiary Hexal AG is planning to appeal a German court’s ruling banning the company from selling its laxative product containing macrogol, a company spokesman said Thursday.

The decision of the Hamburg District Court, which was revealed Monday by European pharmaceutical company Norgine Europe BV, ruled that Hexal and Cassella Med GbmH & Co. KG, a subsidiary of German health care conglomerate Klosterfrau Vertriebs GmbH, were illegally distributing their laxative products as medical devices, when they should have gained approval to market them as medicinal...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.